Lab Scientists at Entos Pharmaceuticals (IMAGE)

Entos Pharmaceuticals

Lab Scientists at Entos Pharmaceuticals

Caption

In preclinical studies, two lead Fusogenix DNA vaccine (Covigenix) candidates demonstrated high immunogenicity and efficacy. Lead candidates to be evaluated in SARS-CoV-2 animal challenge studies and advanced to human clinical trials during summer 2020.

Credit

Michael Wong

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.